LATEST DISCOUNTS & SALES: PROMOTIONS

Close Notification

Your cart does not contain any items

Trial Designs and Outcomes in Dementia Therapeutic Research

Kenneth Rockwood (Dalhousie University, Halifax, Nova Scotia, Canada) Serge Gauthier

$210

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
CRC Press
23 November 2005
"Given the increased attention by clinicians, researchers and the pharmaceutical industry to the management and treatment of dementia not only in the elderly but also in increasingly younger populations, the demands for effective evidence-based pharmaceutical control of dementia and quantitative assessment of outcomes have increased. Since some first steps in the early 1960's (Arthur C. Walsh and the ""anticoagulation-psychotherapy regime"" for ""senile dementia"") to

the controversial if landmark paper of Summers and colleagues, to the most recent trials, it is clear both that much progress has been made, and that much remains to be done. This

book is written to take stock of what is now usefully known, and to speculate on directions for the future."

By:   ,
Imprint:   CRC Press
Country of Publication:   United Kingdom
Dimensions:   Height: 246mm,  Width: 189mm,  Spine: 23mm
Weight:   1.043kg
ISBN:   9781841843216
ISBN 10:   1841843210
Pages:   312
Publication Date:  
Audience:   General/trade ,  Professional and scholarly ,  ELT Advanced ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Kenneth Rockwood MD MPA FRCPC is Professor, Division of Geriatric Medicine, Department of Medicine and Kathryn Allen Weldon Professor of Alzheimer Research, Dalhousie University, Halifax NS, Canada. Serge Gauthier MD FRCPC is Professor and Director of the Alzheimer’s Disease Research Unit, The McGill Centre for Studies in Aging (Le Centre McGill D’Études sur le Vieillissement), Douglas Hospital, Montréal PQ, Canada.

Reviews for Trial Designs and Outcomes in Dementia Therapeutic Research

"""…a thorough and thoughtful examination of a complex area….a milestone in describing the playing field upon which drug trials of Alzheimer's disease should be conducted. It is a testament to how all the measures used to diagnose Alzheimer's disease do not equally gauge the progression of the disease. Alzheimer's disease is not monolithic, but varies greatly from stage to stage. This book promotes new ways of approaching this aspect of the disease."" -Doody's Reviews"


See Also